Pre-close Trading Update

Advanced Medical Solutions Grp PLC
11 July 2006


For Immediate release                                               11 July 2006


                      Advanced Medical Solutions Group plc

                            ('AMS' or 'the Company')


                            Pre-close trading update


Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global
medical technology company, is pleased to update investors on trading as it
enters the close period for the half year ending 30 June 2006.

Dr. Geoffrey Vernon, Chairman of AMS, stated:

'The Company continues to trade in line with our expectations and make steady
progress in delivering a number of major organic growth opportunities.

The recent European approval of its ionic silver alginate woundcare range allows
further expansion into the dynamic silver market.  These products, which have
broad anti-microbial properties that help to prevent infections such as MRSA,
are expected to be introduced during the second half of 2006 through key branded
partners.

The Company continues to make progress with its direct NHS business.   Fourteen
NHS Hospital and Primary Care Trusts across England and Scotland have now
adopted the ActivHeal(R) range of advanced woundcare products allowing them to
achieve substantial cost savings at a time of severe funding pressures without
compromising patient care.  Many more centres are currently evaluating the
product offering.  A number of NHS Ambulance Trusts have also now adopted
LiquiBand(TM) tissue adhesive and are using the product to close trauma wounds
at the point of injury.

Approval of the Company's LiquiBand(TM) tissue adhesives range continues on
track in the US and Far East for 2007, areas which we believe will be of
significant value creation in the future.


                                    - ENDS -


For further information, please contact:

Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $13 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS' resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives that offer benefits over sutures and
staples for closing wounds sold direct to hospitals or through distributors.

AMS' technology and products currently serve the majority of the key global
markets and strategic partners.



                      This information is provided by RNS
            The company news service from the London Stock Exchange